Element Biosciences
Develops genomic and multiomic sequencing platforms for research, translational science, and diagnostics
$175MSeries E
Role not disclosedSE
Samsung Electronics
Activity from announced rounds
Activity in this selectionJun 30, 2026 · Jun 1, 2026
Samsung Electronics is the corporate entity named in Element Biosciences and Mistral financing histories.
Recorded funding activity
Element develops genomic and multi-omic sequencing systems. Mistral develops models and computing infrastructure. These records remain separate from Samsung Securities and Samsung Ventures, with event roles independently reviewable.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $175M 1 disclosed · full round size, not this investor’s share